These assays are widely used in pharmaceutical research to quantify cellular responses to cytotoxic stimuli ... and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, ...
US Cellular will sell select spectrum licenses to AT&T in a $1.02 billion cash deal, continuing to monetize the spectrum not ...
Consumer companies rose sharply amid improving consumer sentiment. The first of two readings in November of consumer sentiment rose to a seven-month high of 73.0, from 70.5 in the prior month, the ...
After selling to T-Mobile and Verizon, US Cellular has sold another chunk of its spectrum to AT&T now. Here’s what it could mean for you.
U.S. consumer sentiment rose to a seven-month high in early November, with a measure of households' expectations for the ...
(Reuters) - United States Cellular said on Thursday it has agreed to sell a portion of spectrum licenses used to transmit ...
UScellular agrees to sell spectrum assets to AT&T for $1.018B as part of strategic monetization plan, reaching deals to monetize majority of holdings.
Intra-Cellular Therapies said on Tuesday its drug to prevent relapses in schizophrenia patients met the main goal of a late-stage trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback